Publication of our work evaluating how seizure-free days are related with other quality of life predictors for patients with Dravet Syndrome and their carers.
Care Pathway Mapping for Dravet Syndrome (DS) Patients in England
A Cost-Effectiveness Analysis of Fenfluramine for the Treatment of Seizures for Patients with Dravet Syndrome (DS) in the UK Setting
Determining the Relationship of Seizures, Seizure Free Days and Other Predictors of Health Related Quality of Life in Patients with Dravet Syndrome (DS) and Their Carers
